Aldosterone target organ protection by eplerenone
- 31 March 2004
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 217 (1-2) , 229-238
- https://doi.org/10.1016/j.mce.2003.10.047
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic HypertensionHypertension, 2003
- Emerging therapies for heart failureEmerging Drugs, 2002
- Rationale for the Use of Aldosterone Antagonists in Congestive Heart FailureDrugs, 2002
- Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-κB Activation in Angiotensin II–Induced Cardiac InjuryHypertension, 2001
- Tissue-specific corticosteroidogenesis in the ratMolecular and Cellular Endocrinology, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Vascular Aldosterone in Genetically Hypertensive RatsHypertension, 1997
- Changes in Left Ventricular Anatomy and Function in Hypertension and Primary AldosteronismHypertension, 1996
- Influence of systemic arterial blood pressure and nonhemodynamic factors on the brachial artery pulsatility index in mild to moderate essential hypertensionThe American Journal of Cardiology, 1993
- Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertensionThe American Journal of Cardiology, 1993